| (Values in U.S. Thousands) | Dec, 2024 | Dec, 2023 | Dec, 2022 | Mar, 2025 | Mar, 2025 |
| Sales | 125,600 | 93,110 | 55,550 | 0 | 0 |
| Sales Growth | +34.89% | +67.61% | unch | unch | unch |
| Net Income | -2,027,010 | -1,465,690 | -5,399,100 | 0 | 0 |
| Net Income Growth | -38.30% | +72.85% | unch | unch | unch |
Grail Inc (GRAL)
27.89 -0.69 (-2.41%) 10:38 ET [NASDAQ]
27.75 x 5 28.15 x 500
Realtime by (Cboe BZX)
27.75 x 5 28.15 x 500
Realtime 29.00 +0.42 (+1.47%) 09:28 ET
for Fri, Mar 28th, 2025
GRAIL LLC is a biotechnology company. It focuses on developing technologies for early cancer detection. GRAIL LLC is based in Menlo Park, United States.
Fiscal Year End Date: 12/31